ERBB2 and breast cancer: Among the Src family members, high Src-1 expression has been directly correlated with HER2 positivity, disease recurrence in HER2-positive BCs and resistance to endocrine therapy [77, 78], and disruption of the Src-1 gene in mice suppresses BC metastasis without affecting primary tumor formation [82].